D Young & Co expands trade marks practice with lateral hire

Posted on 09 June 2025

Charlotte Duly joins the D Young & Co trade mark team as partner from Charles Russell Speechlys where she was Head of Brand Protection.

Team

Charlotte Duly

I entered the fascinating world of intellectual property in 2005 with a focus on trade marks and designs. I enjoy watching the evolution of my clients’ goods and services as their businesses grow and technology develops.I advise on the creation, protection, exploitation and enforcement of intellectual property rights, both in…

News

Change of Munich office address

Posted on 02 June 2025

From Monday 02 June 2025 our Munich team should be contacted at Karlstraße 12, 80333 Munich, Germany.

News

" > IAM Patent 1000 Gold: "technically and legally adept attorneys also garner glowing reviews this year"

Posted on 02 June 2025

We are delighted to announce that we have once again been ranked Gold for Patent Prosecution and Gold in the EPO rankings by IAM Patent 1000.

News

global survey" > Managing IP features UK Trade Mark Attorney Gemma Kirkland in "Top 250 Women in IP" global survey

Posted on 02 June 2025

Congratulations to Trade Mark Attorney Gemma Kirkland who is listed as one of only 24 UK women featured in the Managing IP 2025 "Top 250 Women in IP" survey.

News

IPSTARS 2025: D Young & Co ranked top tier for UK trade mark prosecution work

Posted on 30 May 2025

Congratulations to our trade mark team, which has been once again ranked as a top tier UK practice for trade mark prosecution services in the IPSTARS (Managing IP) global survey.

News

D Young & Co IPSTARS 2025

Posted on 30 May 2025

Partners from across D Young & Co's patent and trade mark teams, in the UK and Germany, feature in this year’s IPSTARS list.

Team

Chris Sharrock

I joined D Young & Co in 2024, and have enjoyed gaining experience in the prosecution and opposition of European patents in the biotechnology sector, utilising my extensive knowledge of cell and molecular biology. I obtained first class honours from the University of York in my Master in Biology degree,…

IP Cases & Articles

Differing decisions from the UPC and EPO: Sanofi v Amgen; EP 3666797B

Posted on 23 May 2025

Following the Munich Central Division decision in the first-filed case of the Unified Patent Court (UPC) between Sanofi-Aventis v Amgen (UPC_CFI_1/2023), the Opposition Division has now issued its decision in the corresponding European Patent Office (EPO) opposition proceedings in which Sanofi is one of the opponents.